Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
FibroBiologics closed a $0.5 million private placement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for the purchase of 298,508 shares and accompanying warrants. The securities were sold at a combined purchase price of $1.675 per unit, with proceeds intended for general corporate purposes and working capital. Additionally, shareholders approved the issuance of over 8 million shares related to a prior June 2026 securities purchase agreement.
Henri J. Steenkamp is stepping down as CFO, Chief Compliance Officer, Treasurer, and Secretary effective October 31, 2026, for health-related reasons, though he will remain on the Board and serve as a consultant. The company promoted Christine Ramdihal to Chief Accounting Officer and Treasurer (Principal Financial Officer) and Rochelle Kracoff to Chief Compliance Officer and Secretary to fill the roles.
Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.
Beazer Homes USA entered into supplemental indentures for its 2031 and 2032 senior notes following a successful consent solicitation by Dream Finders Homes. The amendments redefine 'Change of Control' to ensure the pending merger between the two companies does not trigger debt repayment obligations. This update provides a material status update on the regulatory and structural progress of the previously announced merger.
INVE Technologies appointed James Greenwell as Interim Chief Executive Officer, effective September 21, 2026, following the resignation of Kirsten Newquist. The company will pay executive search firm Korn Ferry approximately $18,000 per week for Mr. Greenwell's services under a statement of work expected to run through March 2027.
20/20 Biolabs, Inc. reported the results of its adjourned annual meeting of stockholders held on September 16, 2026. Stockholders approved a charter amendment to increase the number of authorized shares of common stock from 50 million to 500 million shares.
Americas Carmart Debt Financing Update with Silver Point Finance, LLC
America's Car-Mart, Inc. entered into a third extension of its limited waiver and amendment to its Credit and Guaranty Agreement with Silver Point Finance, extending the termination date to September 24, 2026. The extension provides temporary relief from minimum liquidity and collateral coverage ratio requirements while the company continues to evaluate strategic alternatives and address existing or anticipated events of default. The company is currently in active discussions with third parties regarding potential financing, recapitalization, or restructuring transactions.
Palvella Therapeutics COO Kathleen Goin Sells $655K of Stock
Kathleen Goin, COO, sold 4,302 shares of Palvella Therapeutics, Inc. at $151.16 to $153.24 a share (average $152.24) in 3 transactions, worth $655K in total on Sep 16, 2026. Shares held after the trade: 0 (-100.0%).
Quicklogic Sr. VP and CTO Timothy Saxe Sells $106K of Stock
Timothy Saxe, Sr. VP and CTO, sold 10,364 shares of Quicklogic Corp at $10.21 a share, worth $106K in total on Sep 17, 2026. Shares held after the trade: 152,214 (-6.4%).
Quicklogic President and CEO Brian C. Faith Sells $176K of Stock
Brian C. Faith, President and CEO, sold 17,255 shares of Quicklogic Corp at $10.21 a share, worth $176K in total on Sep 17, 2026. Shares held after the trade: 271,065 (-6.0%).
Ethos Technologies CEO and Secretary Peter George Colis Sells $2.7M of Stock
Peter George Colis, CEO and Secretary, sold 70,000 shares of Ethos Technologies Inc. at $35.98 to $40.35 a share (average $38.51) in 8 transactions, worth $2.7M in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 1,543,855 (-0.6%).
Quicklogic CFO, SVP Finance Elias Nader Sells $84.7K of Stock
Elias Nader, CFO, SVP Finance, sold 8,291 shares of Quicklogic Corp at $10.21 a share, worth $84.7K in total on Sep 17, 2026. Shares held after the trade: 88,845 (-8.5%).
Ethos Technologies President Lingke Wang Sells $4.61M of Stock
Lingke Wang, President, sold 118,333 shares of Ethos Technologies Inc. at $38.36 to $39.67 a share (average $38.96) in 3 transactions, worth $4.61M in total on Sep 17, 2026. Shares held after the trade: 1,537,543 (-0.0%).
Magnite Insider Douglas S. Knopper Sells $981K of Stock
Douglas S. Knopper sold 37,337 shares of Magnite, Inc. at $26.28 a share, worth $981K in total on Sep 17, 2026. Shares held after the trade: 51,136 (-42.2%).
Revvity Please See Remarks Tajinder S. Vohra Sells $1.03M of Stock
Tajinder S. Vohra, Please See Remarks, sold 7,330 shares of Revvity, Inc. at $140.88 a share, worth $1.03M in total on Sep 16, 2026. Shares held after the trade: 6,635 (-52.5%).
3D Systems President and CEO Jeffrey A. Graves Sells $152K of Stock
Jeffrey A. Graves, President and CEO, sold 42,686 shares of 3D Systems Corp at $3.55 a share, worth $152K in total on Sep 17, 2026. Shares held after the trade: 1,231,596 (-3.3%).
Crescent Biopharma CMO Ellie Eunkyung Im Sells $11.2K of Stock
Ellie Eunkyung Im, CMO, sold 623 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.2K in total on Sep 16, 2026. Shares held after the trade: 21,446 (-2.8%).
Crescent Biopharma President and COO Jonathan McNeill Sells $77.2K of Stock
Jonathan McNeill, President and COO, sold 4,570 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.90) in 2 transactions, worth $77.2K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 134,588 (-2.8%).
Crescent Biopharma CFO Richard William Scalzo Sells $10.2K of Stock
Richard William Scalzo, CFO, sold 568 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $10.2K in total on Sep 16, 2026. Shares held after the trade: 19,730 (-2.8%).
Crescent Biopharma CEO Joshua T. Brumm Sells $160K of Stock
Joshua T. Brumm, CEO, sold 9,447 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.91) in 2 transactions, worth $160K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 271,765 (-2.8%).
Crescent Biopharma Insider Barbara Harlin Bispham Sells $11.1K of Stock
Barbara Harlin Bispham sold 620 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.1K in total on Sep 16, 2026. Shares held after the trade: 18,710 (-3.2%).
Proto Labs CFO Daniel Schumacher Sells $418K of Stock
Daniel Schumacher, CFO, sold 4,900 shares of Proto Labs Inc at $85.21 a share, worth $418K in total on Sep 17, 2026. Shares held after the trade: 40,019 (-10.9%).
Mercury Systems received preliminary court approval for the settlement of two consolidated stockholder derivative actions, Jones v. Aslett and McKinnon v. Aslett. The settlement resolves litigation originally agreed upon in July 2026, with the court issuing formal orders granting preliminary approval on September 9 and September 15, 2026.
Counterparty
Essex County Superior Court for the Commonwealth of Massachusetts
Fuel Tech, Inc. has posted an updated corporate presentation to its website and filed it as an exhibit to this 8-K. The presentation, dated September 14, 2026, provides a strategic overview of the company's operations and technology for investors.
Omega Flex, Inc. declared a regular quarterly cash dividend of $0.34 per share for the third quarter of 2026. The dividend is payable on October 14, 2026, to shareholders of record as of the close of business on September 30, 2026.
KKR FS Income Trust issued and sold 127,341.992 Class I shares for approximately $3.705 million as part of its ongoing continuous private offering. The company also reported a net asset value (NAV) per share of $29.10 as of August 31, 2026, with total offering proceeds to date reaching approximately $1.769 billion.
Zoomcar Holdings, Inc. completed the sixth closing of its private placement of Series A units, raising approximately $155,000 in gross proceeds. Each unit, sold at $1,000, consists of one share of Series A Convertible Preferred Stock and a warrant to purchase 20,000 shares of common stock. The company has agreed to file a registration statement for the resale of the underlying common stock within 15 days of the closing.
Carlyle Credit Solutions declared a quarterly dividend of $0.14 per share for Class I common stock, payable on October 28, 2026. The company also disclosed it raised $10.3 million through the issuance of 569,592 shares as part of its ongoing continuous private offering and reported a net asset value (NAV) per share of $18.05 as of August 31, 2026.
Mesa Royalty Trust announced that there will be no cash distribution for the month of September 2026. The suspension is due to costs and expenses exceeding royalty revenues from its oil and gas properties, as well as the Trust's ongoing effort to build a $2.0 million cash reserve for liquidity.
Cemtrex Inc. announced that its Board of Directors has authorized the payment of a semi-annual dividend on its Series 1 Preferred Stock in the form of additional shares of the same stock. The dividend is based on a 10% annual rate on a $10.00 per share preference amount and will be issued on October 7, 2026, to shareholders of record as of September 30, 2026.